Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
12.9%
% of XLV's 65 holdings also in PTH
15.1%
% of PTH's 53 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PTH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PTH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.9% | 4.8% | 4.8% |
|
INTUITIVE SURGICAL INC | 3.3% | 2.6% | 2.6% |
|
ABBVIE INC | 6.1% | 2.6% | 2.6% |
|
REGENERON PHARMACEUTICALS | 1.8% | 2.2% | 1.8% |
|
HCA HOLDINGS INC | 1.2% | 3.1% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PTH
|
UNITEDHEALTH GROUP INC | 9.5% |
|
ELI LILLY & CO | 8.1% |
|
JOHNSON & JOHNSON | 7.1% |
|
MERCK & CO. INC. | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
ABBOTT LABORATORIES | 3.6% |
|
ABBVIE INC | 3.5% |
|
AMGEN INC | 3.1% |
|
PFIZER INC | 3.0% |
|
DANAHER CORP | 2.9% |
XLV Underweight Relative to PTH
|
VAXCYTE, INC. | -4.6% |
|
INSMED INC | -3.9% |
|
TENET HEALTHCARE CORP | -3.4% |
|
CASSAVA SCIENCES, INC. | -3.0% |
|
NATERA INC | -2.8% |
|
NURIX THERAPEUTICS, INC. | -2.4% |
|
CATALYST PHARMACEUTICAL PART | -2.4% |
|
HARROW INC | -2.4% |
|
DAVITA INC | -2.2% |
|
ADMA BIOLOGICS, INC. | -2.2% |